This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Related letters  • Similar articles in JAMA  Topic Collections  • Neurology  • Cognitive Disorders  • Critical Care/ Intensive Care Medicine  • Adult Critical Care  • Psychiatry  • Delirium  • Drug Therapy  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To The Editor: In the MENDS trial, Dr Pandharipande and colleagues¹ concluded that dexmedetomidine infusion resulted in more days alive without delirium or coma and more time at the targeted level of sedation than with a lorazepam infusion. It remains unclear whether the study findings are due to the benefits of dexmedetomidine or are a result of the study design itself.

The trial was designed so that an increase of 1 mL per hour of the unknown drug resulted in an increase of either 0.15 µg per hour in dexmedetomidine or 1.0 mg per hour in lorazepam. These are not equivalent doses of medications, as demonstrated by the reported median infusion rate for dexmedetomidine of 5 mL per hour and, for lorazepam, only 3 mL per hour. Moreover, dexmedetomidine has a much shorter half-life (2-3 hours) compared with lorazepam (10 hours).^2-3

This nonequivalence of drug raises a number of questions. . . . [Full Text of this Article]

Hannah Wunsch, MD, MSc
hw2125@columbia.edu

Joseph S. Meltzer, MD
Department of Anesthesiology
Columbia University College of Physicians and Surgeons
New York, New York

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED ARTICLE

Effect of Sedation With Dexmedetomidine vs Lorazepam on Acute Brain Dysfunction in Mechanically Ventilated Patients: The MENDS Randomized Controlled Trial
Pratik P. Pandharipande, Brenda T. Pun, Daniel L. Herr, Mervyn Maze, Timothy D. Girard, Russell R. Miller, Ayumi K. Shintani, Jennifer L. Thompson, James C. Jackson, Stephen A. Deppen, Renee A. Stiles, Robert S. Dittus, Gordon R. Bernard, and E. Wesley Ely
JAMA. 2007;298(22):2644-2653.
ABSTRACT | FULL TEXT  

RELATED LETTERS

Sedation With Dexmedetomidine vs Lorazepam in Mechanically Ventilated Patients
Bryan Dotson and Michael J. Peeters
JAMA. 2008;299(13):1540.
EXTRACT | FULL TEXT  

Sedation With Dexmedetomidine vs Lorazepam in Mechanically Ventilated Patients
Jeffrey F. Barletta and John W. Devlin
JAMA. 2008;299(13):1541-1542.
EXTRACT | FULL TEXT  

Sedation With Dexmedetomidine vs Lorazepam in Mechanically Ventilated Patients—Reply
Pratik P. Pandharipande, Timothy D. Girard, and E. Wesley Ely
JAMA. 2008;299(13):1542.
EXTRACT | FULL TEXT